General Hospital Medicine   

Do you find it helpful to monitor for treatment response, resolution, and/or recurrence?

How do factors like the presence of varices, severity of coagulopathy, etc., play into your decision?

For example, what do you do when someone requests aggressive, life-prolonging treatments but then is not receptive to elements of day-to-day care in t...

In particular, how do you reconcile situations where lung POCUS findings contradict other components of volume assessment (e.g. JVD, peripheral edema,...

If the patient does not have underlying diabetes, do the benefits of an insulin drip for this indication outweigh the risks?

For example, do you find trending WBC, procalcitonin, CRP, etc., more or less helpful?

What situations prompt you to prescribe dexamethasone to complete a 10-day course at discharge?

In other words, are there benefits to identifying URI pathogens that do not necessarily have targeted therapies (e.g., rhinovirus, non-COVID-19 Corona...

While many US guidelines have supported a threshold of > 50k, there does not appear to be robust data to support it. Notably, the 2025 AABB and ICT...

How would you decide on the duration of antibiotics in this case?

For example, do you consider "cautious" IV fluids or otherwise consider early vasopressors?

Do you use the traditional strict limit of 1.5 L, or do you consider removing more volume if a patient appears to tolerate it?